| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |